Hyperphosphatemia activates multiple signaling pathways, including NF-κB, Wnt/β-catenin, and BMP-2/Smad, inducing osteogenic phenotypic transformation of vascular smooth muscle cells (VSMCs) [23]. Here, NFKB1 is linked to hyperphosphatemia.